Most Australians want smoother, younger-looking skin but the thought of needles, clinic visits or pricey treatments can put many off. That’s where Transdermic skincare comes in, offering advanced anti-aging skincare solutions that work without injections. By harnessing very low molecular weight actives and patented delivery systems, Transdermic Technology (used by brands like Labo Suisse and Fillerina) enables substances such as hyaluronic acid, collagen and elastin to penetrate into deeper skin layers. In this article we’ll explore the scientific evidence behind Transdermic skincare, how it compares with traditional creams and injectable fillers, and why Fillerina by Labo Suisse may be your best non-invasive option.
What exactly is Transdermic Technology?
Definition & Patent
Transdermic Technology is a Swiss‐patented system developed by Labo Suisse. It is designed to deliver active molecules through both the epidermis and dermis without injections. The company holds patents such as Swiss Patent CH 711 466 (“Transdermal technology, enhanced penetration properties”) and others related to rapid penetration dermal fillers for topical use.
Mechanism: Molecular size & penetration tests
A key to Transdermic Technology is using smaller molecular weights of active ingredients. Ex vivo tests (using Franz Cells) show that Labo’s formulas with multiple hyaluronic acids (ranging from about 400 to 2,000,000 Dalton in some Fillerina 12HA formulas) penetrate more effectively into skin layers. “Very low molecular weight” molecules are fundamental to guarantee absorption into both epidermis and dermis.
Clinical trials & evidence
A well-documented clinical trial (double-blind, randomised, placebo-controlled) involving 40 women with mild-to-moderate skin ageing examined Fillerina’s six-type hyaluronic acid treatment. Over 30 days of daily use, there were measurable improvements: lip volume increased by ~14.2%, cheekbone volume increased, wrinkle volume decreased by ~26.3%, and wrinkle depth by ~21.8%. While the study does not always explicitly say “this was due to Transdermic Technology” in those quantitative results, Fillerina’s product claims, and Labo’s descriptions, attribute these effects to its multi-molecular HA formulation and patented delivery / penetration technology. Thus, the trial offers strong empirical support consistent with the promises of Transdermic Technology.
Transdermic vs. Conventional Skincare Creams
Transdermic skincare offers substantially better penetration and therefore more visible results than many standard creams.
Transdermic Skincare vs. Injectable Fillers
- Safety & Non-Invasiveness: Injectable fillers work well but require professional application, carry risk of bruising/infection, cost, and downtime. Transdermic skincare avoids injections, which for many people is more appealing.
- Longevity & Natural Results: Injectable fillers can give immediate lift and volume, but come with risks of overfilling or unnatural look. Transdermic product use over time (such as with Fillerina) shows progressive improvement with a more subtle, natural effect. The clinical trial’s results over 30 days support this gradual improvement.
- Cost & Convenience: Using topical Transdermic Skincare (available via retail or specialist skincare providers) allows daily usage in your routine, without repeated clinician visits. More accessible for many.
Considerations & Limitations
- Not Equivalent to Medical Injections: Transdermic skincare will not (and should not) deliver the same immediate, volumising “lift” that high-volume injectable fillers do. For deep folds or extensive volume loss, injectable treatments still have a place.
- Consistency & correct usage matter: Results depend heavily on regular use, appropriate grade (strength) of product, and choosing one suited to your skin type. Over-promise or misuse may lead to disappointment.
- Skin barrier & individual variation: Factors like skin thickness, age, sun damage, hydration, and genetic variation influence how well active molecules penetrate. While Transdermic Technology improves penetration, not everyone will get identical results.
Is Transdermic Skincare the Smarter Choice?
For Australians seeking visible anti-aging outcomes without injections, Transdermic skincare offers a compelling alternative. The scientific study of Fillerina’s multi-HA formula shows measurable improvements in volume, wrinkle depth, and facial contour over 30 days. Added to that, Labo Suisse’s patents (including CH 711 466), product lines emphasising multiple HA molecular weights, penetration testing via Franz Cells, and formulations designed for different skin needs, all support that Transdermic Technology is not just marketing speak but has empirical backing.
Curious to see the difference for yourself?
Discover the power of Transdermic Technology with our Fillerina range. If you need guidance, our skincare experts are here to help. Find your perfect grade today and enjoy visible anti-aging results, no needles, just science-backed skincare.
